Search Within

Andrew D Zelenetz

  1. "Journal of Nuclear Medicine"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Lymphoma (6)
  5. Molecular Imaging and Therapy Service (4)
  6. Radiology, Department of (4)

More Groups

People
  1. Chaitanya Divgi (3)
  2. Steven Larson (3)
  3. Ase Ballangrud-Popovic (2)
  4. Heiko Schoder (2)
  5. Jerrold Teitcher (2)
  6. Katherine Kolbert (2)

More People

Years
  1. 2023 (1)
  2. 2016 (1)
  3. 2003 (3)
  4. 2001 (1)
Publications
  1. Journal of Nuclear Medicine (6)
Publishers
  1. Society of Nuclear Medicine (6)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of (18)F-FDG PET/CT in diffuse large B-cell lymphoma treated with a risk-adapted immunochemotherapy regimen
    Journal Article

    Michaud, L.; Bantilan, K.; Mauguen, A.; Moskowitz, C. H.; Zelenetz, A. D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Prospective study of 3′-deoxy-3′-(18)F-fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma
    Journal Article

    Schoder, H.; Zelenetz, A. D.; Hamlin, P.; Gavane, S.; Horwitz, S.; Matasar, M.; Moskowitz, A.; Noy, A.; Palomba, L.; Portlock, C.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Bexxar® (tositumomab and iodine I 131 tositumomab) is well tolerated and efficacious in heavily pretreated patients with non-Hodgkin's lymphoma (NHL) and mild thrombocytopenia
    Meeting Abstract

    Goldsmith, S. J.; Kostakoglu, L.; Wahl, R.; Alavi, A.; Divgi, C.; Hankins, J.; Zelenetz, A.; Kaminski, M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Correlation of tumor radiation-absorbed dose with response is easier to find in previously untreated patients - Reply
    Journal Article

    Sgouros, G.; Squeri, S.; Ballangrud, A. M.; Kolbert, K.; Teitcher, J. B.; Panageas, K. S.; Finn, R. D.; Divgi, C. R.; Larson, S. M.; Zelenetz, A. D.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: Assessment of tumor dose-response
    Journal Article

    Sgouros, G.; Squeri, S.; Ballangrud, A. M.; Kolbert, K. S.; Teitcher, J. B.; Panageas, K. S.; Finn, R. D.; Divgi, C. R.; Larson, S. M.; Zelenetz, A. D.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Dosimetry optimizes tumor dose & enhances safety in non-hodgkins lymphoma patients [PTS] treated with I-131 tositumomab [Bexxar ™]
    Meeting Abstract

    Goldsmith, S. J.; Kaminski, M.; Wahl, R.; Vose, J.; Zelenetz, A.; Kroll, S.; Clapp, K.; Leonard, J. L.; Presbyterian, N. Y.
    Journal of Nuclear Medicine (2001)

    Fulltext@MSK | Save